Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 CAD | +0.77% | -2.96% | 0.00% |
Apr. 15 | RBC Capital Markets Gives Nutrien Outperform Rating, US$70 Price Target | MT |
Apr. 01 | Itafos Continues the Process to Explore and Evaluate Various Strategic Alternatives | CI |
Sales 2022 | 593M 810M | Sales 2023 | 466M 636M | Capitalization | 188M 257M |
---|---|---|---|---|---|
Net income 2022 | 115M 157M | Net income 2023 | 3M 4.1M | EV / Sales 2022 | 0.51 x |
Net Debt 2022 | 101M 138M | Net Debt 2023 | 72.79M 99.42M | EV / Sales 2023 | 0.56 x |
P/E ratio 2022 |
1.76
x | P/E ratio 2023 |
49.4
x | Employees | 417 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 31.93% |
1 day | +0.77% | ||
1 week | -2.96% | ||
Current month | -1.50% | ||
1 month | +2.34% | ||
3 months | -2.96% | ||
6 months | +2.34% |
Managers | Title | Age | Since |
---|---|---|---|
George Delaney
CEO | Chief Executive Officer | 63 | 17-02-05 |
Matthew O’Neill
DFI | Director of Finance/CFO | - | 22-08-10 |
Tim Vedder
COO | Chief Operating Officer | - | 18-01-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 21-08-30 | |
George Delaney
CEO | Chief Executive Officer | 63 | 17-02-05 |
Ronald Wilkinson
BRD | Director/Board Member | - | 18-01-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.31 | +0.77% | 45 416 |
24-04-25 | 1.3 | -1.52% | 67,100 |
24-04-24 | 1.32 | -2.22% | 129,200 |
24-04-23 | 1.35 | +2.27% | 129,353 |
24-04-22 | 1.32 | -2.22% | 29,693 |
Delayed Quote Toronto S.E., April 26, 2024 at 02:07 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 182M | |
+0.55% | 15.01B | |
-21.27% | 13.81B | |
+3.13% | 12.07B | |
-15.21% | 9.73B | |
-.--% | 7.3B | |
-5.39% | 6.31B | |
-5.36% | 3.93B | |
-28.77% | 2.37B | |
+2.37% | 2.08B |
- Stock Market
- Equities
- IFOS Stock